A detailed history of Intech Investment Management LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Intech Investment Management LLC holds 42,616 shares of AKRO stock, worth $2.31 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
42,616
Previous 41,887 1.74%
Holding current value
$2.31 Million
Previous $2.24 Million 9.49%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

BUY
$42.18 - $54.33 $30,749 - $39,606
729 Added 1.74%
42,616 $2.02 Million
Q2 2025

Aug 08, 2025

SELL
$34.04 - $56.28 $566,255 - $936,217
-16,635 Reduced 28.43%
41,887 $2.24 Million
Q1 2025

May 20, 2025

BUY
$21.87 - $57.56 $450,959 - $1.19 Million
20,620 Added 54.4%
58,522 $2.37 Million
Q4 2024

Feb 10, 2025

BUY
$26.75 - $35.28 $556,266 - $733,647
20,795 Added 121.56%
37,902 $1.05 Million
Q3 2024

Nov 08, 2024

BUY
$21.45 - $29.34 $366,945 - $501,919
17,107 New
17,107 $490,000

Others Institutions Holding AKRO

About Akero Therapeutics, Inc.


  • Ticker AKRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,417,600
  • Market Cap $2.52B
  • Description
  • Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...
More about AKRO
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.